·   Log in

Archive for October 16th, 2009

Vaccine for nicotine addiction NIC002 flunks: Cytos

Friday, October 16, 2009 14:07

Novartis, which bought the rights to the NIC002, will continue to develop the anti-smoking vaccine

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with:

Anti-CCP test to diagnose rheumatoid arthritis gets US FDA approval: Axis-Shield

Friday, October 16, 2009 12:59

An assay for anti-CCP to test rheumatoid arthritis (RA) by Axis-Shield plc has been granted marketing approval in US.

This was posted under category: medical devices  |  Read Full Story  |  0 Comments

BNC210 anxiety drug compound less-addictive, says Bionomics

Friday, October 16, 2009 12:58

BNC210, an anxiety drug compound being developed by Bionomics, has been found superior to several existing anti-anxiety, stress drugs and less addictive in clinical studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

HIV drugs with no side effect could become a reality soon

Friday, October 16, 2009 12:14

Side-effect free, less toxic anti-HIV drug may well be underway.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with:

Wockhardt’s alfuzosin (Uroxatral) generic pills to treat prostate disease get tentative approval in US

Friday, October 16, 2009 12:13

India's Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for a generic version of alfuzosin, a drug used in the treatment of prostate disease.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: